| Report Title | Price | Action |
|---|---|---|
| Envelope Protein M (Matrix Protein) - Drugs in Development, 2021
Envelope Protein M (Matrix Protein) - Drugs in Development, 2021 Summary Envelope Protein M (Matrix Protein) - Drugs in Development, 2021 provides i...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Limb-Girdle Muscular Dystrophy (Musculoskeletal Disorders) - Drugs in Development, 2021
Limb-Girdle Muscular Dystrophy (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Limb-Girdle Muscular Dystrophy (Musculoskeletal Diso...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Nongerminomatous (Nonseminomatous) Germ Cell Tumors (Oncology) - Drugs in Development, 2021
Nongerminomatous (Nonseminomatous) Germ Cell Tumors (Oncology) - Drugs in Development, 2021 Summary Nongerminomatous (Nonseminomatous) Germ Cell Tum...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Postoperative Ileus (Gastrointestinal) - Drugs in Development, 2021
Postoperative Ileus (Gastrointestinal) - Drugs in Development, 2021 Summary Postoperative Ileus (Gastrointestinal) - Drugs in Development, 2021 prov...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Peripheral Artery Occlusive Disease (PAOD) (Cardiovascular) - Drugs in Development, 2021
Peripheral Artery Occlusive Disease (PAOD) (Cardiovascular) - Drugs in Development, 2021 Summary Peripheral Artery Occlusive Disease (PAOD) (Cardiov...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Cartilage Degeneration (Musculoskeletal) - Drugs in Development, 2021
Cartilage Degeneration (Musculoskeletal) - Drugs in Development, 2021 Summary Cartilage Degeneration (Musculoskeletal) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Thyroid Hormone Receptor Alpha (Nuclear Receptor Subfamily 1 Group A Member 1 or V erbA Related Protein 7 or c erbA 1 or c erbA Alpha or EAR7 or THRA) - Drugs in Development, 2021
Thyroid Hormone Receptor Alpha (Nuclear Receptor Subfamily 1 Group A Member 1 or V erbA Related Protein 7 or c erbA 1 or c erbA Alpha or EAR7 or THRA)...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Integrin Alpha 5 (CD49 Antigen Like Family Member E or Fibronectin Receptor Subunit Alpha or Integrin Alpha F or VLA 5 or CD49e or ITGA5) - Drugs in Development, 2021
Integrin Alpha 5 (CD49 Antigen Like Family Member E or Fibronectin Receptor Subunit Alpha or Integrin Alpha F or VLA 5 or CD49e or ITGA5) - Drugs in D...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| FAD-Dependent Decaprenylphosphoryl-Beta-D-Ribofuranose 2-Oxidase (Decaprenylphospho-Beta-D-Ribofuranose 2-Dehydrogenase or Decaprenylphosphoryl-Beta-D-Ribofuranose 2'-Epimerase 1 or dprE1 or EC 1.1.98.3) - Drugs in Development, 2021
FAD-Dependent Decaprenylphosphoryl-Beta-D-Ribofuranose 2-Oxidase (Decaprenylphospho-Beta-D-Ribofuranose 2-Dehydrogenase or Decaprenylphosphoryl-Beta-D...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Angiosarcoma (Oncology) - Drugs in Development, 2021
Angiosarcoma (Oncology) - Drugs in Development, 2021 Summary Angiosarcoma (Oncology) - Drugs in Development, 2021 provides an overview of the Angios...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Plasma Cell Neoplasm (Oncology) - Drugs in Development, 2021
Plasma Cell Neoplasm (Oncology) - Drugs in Development, 2021 Summary Plasma Cell Neoplasm (Oncology) - Drugs in Development, 2021 provides an overvi...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021
Primary Hyperoxaluria (Genito Urinary System And Sex Hormones) - Drugs in Development, 2021 Summary Primary Hyperoxaluria (Genito Urinary System And...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Peripheral Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021
Peripheral Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021 Summary Peripheral Neuropathic Pain (Central Nervous System) - Dru...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Cerebral Infarction (Brain Infarction) (Central Nervous System) - Drugs in Development, 2021
Cerebral Infarction (Brain Infarction) (Central Nervous System) - Drugs in Development, 2021 Summary Cerebral Infarction (Brain Infarction) (Central...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Toll Like Receptor Family (TLR) - Drugs in Development, 2021
Toll Like Receptor Family (TLR) - Drugs in Development, 2021 Summary Toll Like Receptor Family (TLR) - Drugs in Development, 2021 provides in depth ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Interleukin 33 (Interleukin 1 Family Member 11 or IL1F11 or Nuclear Factor From High Endothelial Venules or NFHEV or IL33) - Drugs in Development, 2021
Interleukin 33 (Interleukin 1 Family Member 11 or IL1F11 or Nuclear Factor From High Endothelial Venules or NFHEV or IL33) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 | |
| Fibroblast Growth Factor 21 (FGF21) - Drugs in Development, 2021
Fibroblast Growth Factor 21 (FGF21) - Drugs in Development, 2021 Summary Fibroblast Growth Factor 21 (FGF21) - Drugs in Development, 2021 provides i...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Low-Grade Glioma (Oncology) - Drugs in Development, 2021
Low-Grade Glioma (Oncology) - Drugs in Development, 2021 Summary Low-Grade Glioma (Oncology) - Drugs in Development, 2021 provides an overview of th...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
| Bacterial Keratitis (Ophthalmology) - Drugs in Development, 2021
Bacterial Keratitis (Ophthalmology) - Drugs in Development, 2021 Summary Bacterial Keratitis (Ophthalmology) - Drugs in Development, 2021 provides a...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Ependymoma (Oncology) - Drugs in Development, 2021
Ependymoma (Oncology) - Drugs in Development, 2021 Summary Ependymoma (Oncology) - Drugs in Development, 2021 provides an overview of the Ependymoma...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 |